AUTL vs. ATRA

In the year-to-date period, AUTL achieves a -42.55% return, which is significantly higher than ATRA's -51.39% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Autolus Therapeutics plc (AUTL) and Atara Biotherapeutics, Inc. (ATRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AUTL Sharpe Ratio is -0.88, which is lower than the ATRA Sharpe Ratio of -0.44. The chart below compares the historical Sharpe Ratios of AUTL and ATRA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither AUTL nor ATRA has paid dividends to shareholders.

The maximum AUTL drawdown since its inception was -97.63%, roughly equal to the maximum ATRA drawdown of -99.67%. Use the drawdown chart below to compare losses from any high point for AUTL and ATRA. For additional features, visit the drawdowns tool.

Autolus Therapeutics plc (AUTL) has a higher volatility of 32.10% compared to Atara Biotherapeutics, Inc. (ATRA) at 25.50%. This indicates that AUTL's price experiences larger fluctuations and is considered to be riskier than ATRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Autolus Therapeutics plc and Atara Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.